Quantitative Assessment of Vacuolization of Myeloid Precursors in VEXAS Syndrome
- PMID: 36751512
- PMCID: PMC9894342
- DOI: 10.1097/HS9.0000000000000828
Quantitative Assessment of Vacuolization of Myeloid Precursors in VEXAS Syndrome
Figures


Similar articles
-
Paradigm shift in monogenic autoinflammatory diseases and systemic vasculitis: The VEXAS syndrome.Med Clin (Barc). 2022 Nov 25;159(10):489-496. doi: 10.1016/j.medcli.2022.06.018. Epub 2022 Aug 29. Med Clin (Barc). 2022. PMID: 36049972 Review. English, Spanish.
-
A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasm.Blood Adv. 2022 Jan 25;6(2):405-409. doi: 10.1182/bloodadvances.2021005243. Blood Adv. 2022. PMID: 34649277 Free PMC article.
-
The VEXAS Syndrome: Uncontrolled Inflammation and Macrocytic Anaemia in a 77-Year-Old Male Patient.Eur J Case Rep Intern Med. 2021 Apr 13;8(4):002484. doi: 10.12890/2021_002484. eCollection 2021. Eur J Case Rep Intern Med. 2021. PMID: 33987129 Free PMC article.
-
Looking beyond VEXAS: Coexistence of undifferentiated systemic autoinflammatory disease and myelodysplastic syndrome.Semin Hematol. 2021 Oct;58(4):247-253. doi: 10.1053/j.seminhematol.2021.10.003. Epub 2021 Oct 9. Semin Hematol. 2021. PMID: 34802547 Review.
-
Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.Semin Hematol. 2021 Oct;58(4):204-211. doi: 10.1053/j.seminhematol.2021.10.007. Epub 2021 Oct 22. Semin Hematol. 2021. PMID: 34802541 Review.
Cited by
-
Recurrent Mutations of the Active Adenylation Domain of UBA1 in Atypical Form of VEXAS Syndrome.Hemasphere. 2023 Mar 24;7(4):e868. doi: 10.1097/HS9.0000000000000868. eCollection 2023 Apr. Hemasphere. 2023. PMID: 36999004 Free PMC article. No abstract available.
-
Use of flow cytometric light scattering to recognize the characteristic vacuolated marrow cells in VEXAS syndrome.Blood Adv. 2023 Oct 24;7(20):6151-6155. doi: 10.1182/bloodadvances.2023010456. Blood Adv. 2023. PMID: 37477595 Free PMC article. No abstract available.
-
Expanding the VEXAS diagnostic workup: the role of peripheral blood cytological analysis.Front Immunol. 2024 Oct 3;15:1466720. doi: 10.3389/fimmu.2024.1466720. eCollection 2024. Front Immunol. 2024. PMID: 39421750 Free PMC article.
-
VEXAS syndrome: a newly discovered systemic rheumatic disorder.Reumatologia. 2023;61(2):123-129. doi: 10.5114/reum/163090. Epub 2023 May 10. Reumatologia. 2023. PMID: 37223371 Free PMC article. Review.
-
VEXAS without vacuoles: Linking genotype to phenotype.EJHaem. 2024 Oct 5;5(5):981-986. doi: 10.1002/jha2.1016. eCollection 2024 Oct. EJHaem. 2024. PMID: 39415928 Free PMC article.
References
-
- Bourbon E, Heiblig M, Gerfaud-Valentin M, et al. . Therapeutic options in Vexas syndrome: insights from a retrospective series. Blood. 2021;137:3682–3684. - PubMed
-
- Lacombe V, Prevost M, Bouvier A, et al. . Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold. Br J Haematol. 2021;195:286–289. - PubMed
LinkOut - more resources
Full Text Sources